Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Oxf Med Case Reports ; 2019(8): omz081, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31772748

ABSTRACT

Gastric cancer represents the fifth most common cancer diagnosis worldwide and the third leading cause of cancer-related mortality. In the USA, the overall 5-year survival rate is 31%, with distant disease nearing 5%. The most common sites of metastasis are the liver and peritoneum. Skeletal muscle involvement has been rarely reported. Since clinical and imaging findings overlap with primary sarcomas, a confirmatory biopsy is required for diagnosis. Prognosis remains poor with treatment options including palliative chemotherapy, radiotherapy and surgical resection. We report the case of a 57-year-old female presenting with extensive involvement of skeletal muscle 10 years after achieving remission. In addition to illustrating the refractoriness and poor outcomes associated with muscle involvement, this case and comprehensive review of the literature highlights important characteristics of disease biology and tumor genomics that warrant detailed discussion and exposition to a wider audience.

2.
Transplant Proc ; 49(2): 373-377, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28219601

ABSTRACT

Syndrome of inappropriate anti-diuretic hormone (SIADH) has been reported to be associated with systemic Strongyloides stercoralis. Here, we report a case of a stem cell transplant (SCT) recipient who developed severe SIADH secondary to systemic S Stercoralis. The SIADH resolved quickly after treating the systemic S Stercoralis with ivermectin. A systematic review of the literature was performed by PubMed, Scopus, and Cochrane database search. Only eight cases of S Stercoralis in allogeneic SCT recipients have been previously reported. To our knowledge, ours is the first reported case of SIADH secondary to S Stercoralis infection in an allogeneic SCT recipient. Prior to transplantation, even if asymptomatic, patients from endemic regions should be screened with strongyloides immunoglobulin (Ig)G serology. Pretransplantation eosinophilia should be evaluated by screening multiple stool samples for ova and parasites. Transplant candidates with positive serology or stool tests can be treated pretransplantation to eradicate infection. Patients at risk for S Stercoralis who develop nonspecific gastrointestinal complaints, rash, pulmonary infiltrates, or gram-negative bacteremia or meningitis may have S Stercoralis hyperinfection syndrome. Our case indicates that the development of SIADH may be an additional clue to this diagnosis. Appropriate diagnostic studies, including repeat stool and other body fluid sampling, should be expedited and ivermectin therapy initiated rapidly to prevent significant morbidity and mortality.


Subject(s)
Duodenal Diseases/parasitology , Inappropriate ADH Syndrome/parasitology , Opportunistic Infections/complications , Stem Cell Transplantation , Strongyloides stercoralis , Strongyloidiasis/complications , Aged , Animals , Antinematodal Agents/adverse effects , Antinematodal Agents/therapeutic use , Duodenal Diseases/drug therapy , Eosinophilia/parasitology , Humans , Immunoglobulin G/blood , Ivermectin/therapeutic use , Male , Opportunistic Infections/drug therapy , Postoperative Complications/drug therapy , Postoperative Complications/parasitology , Transplantation, Homologous
4.
Pediatr Transplant ; 17(2): E55-61, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23230886

ABSTRACT

BKV is known to cause allograft failure in kidney transplant recipients. It has been recently recognized to cause native kidney nephropathy in non-kidney transplant recipients. This is a case report BKVN in a 15-yr-old HTx recipient who had PTLD and a review of pediatric cases in the literature. The patient was diagnosed with BKVN +189 months after transplantation and died thirty days after diagnosis of BKVN. We identified five other cases of BKVN in pediatric non-kidney solid organ transplantation, of which all were HTx recipients. Overall, outcome was poor and BKV clearance was not achieved with reduction of immunosuppression and with current therapies. We strongly recommend that pediatric HTx recipients be tested for BKV infection if there is evidence of kidney dysfunction. We also recommend that they have an annual screening for BKV viruria and viremia with the assessment of kidney function.


Subject(s)
BK Virus , Heart Transplantation , Kidney Diseases/diagnosis , Lymphoma, T-Cell, Peripheral/diagnosis , Polyomavirus Infections/diagnosis , Postoperative Complications/diagnosis , Tumor Virus Infections/diagnosis , Adolescent , BK Virus/isolation & purification , Fatal Outcome , Humans , Kidney Diseases/etiology , Kidney Diseases/virology , Lymphoma, T-Cell, Peripheral/etiology , Male , Polyomavirus Infections/etiology , Postoperative Complications/virology , Tumor Virus Infections/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...